Glypican-3 Targeting of Liver Cancer Cells Using Multifunctional Nanoparticles by James O. Park, Zachary Stephen, Conroy Sun, Omid Veiseh, Forrest M. Kievit, Chen Fang, Matthew Leung, Hyejung Mok, Miqin Zhang

“…Imaging is essential in accurately detecting, staging, and treating primary liver cancer (hepatocellular carcinoma [HCC]), one of the most prevalent and lethal malignancies. …”
Get full text

Glucosamine-Modified Reduction-Responsive Polymeric Micelles for Liver Cancer Therapy by Lei Meng, Fangshu Liu, Chenchen Du, Jiaying Zhu, Qian Xiong, Jing Li, Weitong Sun

Subjects: “…liver cancer…”
Get full text

Chinese Herbal Medicine for Primary Liver Cancer Therapy: Perspectives and Challenges by Kexin Li, Kexin Li, Kunmin Xiao, Kunmin Xiao, Shijie Zhu, Yong Wang, Wei Wang, Wei Wang, Wei Wang

Subjects: “…primary liver cancer…”
Get full text

Toward reproducible tumor organoid culture: focusing on primary liver cancer by Lianming Guo, Chao Li, Weiqiang Gong

Subjects: Get full text

Multimodal deep learning for liver cancer applications: a scoping review by Aisha Siam, Abdel Rahman Alsaify, Bushra Mohammad, Md. Rafiul Biswas, Hazrat Ali, Zubair Shah

Subjects: Get full text

Liver cancer mortality in Mexico: trend analysis from 1998 to 2018 by Christian S Álvarez, Priscilla Espinosa-Tamez, Ruy López-Ridaura, Héctor Lamadrid-Figueroa, Javier Melchor-Ruan, Katherine A McGlynn, Martín Lajous

Subjects: “…liver cancer…”
Get full text

State of the science on outdoor air pollution exposure and liver cancer risk by Trang VoPham, Rena R. Jones

Subjects: Get full text

Editorial: Radiofrequency ablation in liver cancers: Investigations of efficacy as monotherapy and polytherapy by Gianluca Rompianesi

Subjects: “…liver cancer…”
Get full text

The current trends in the health burden of primary liver cancer across the globe by Peter Konyn, Aijaz Ahmed, Donghee Kim

Get full text

The latest global burden of liver cancer: A past and present threat by Joo Hyun Oh, Dae Won Jun

Get full text

Oncostatin M: From Intracellular Signaling to Therapeutic Targets in Liver Cancer by Alessandra Caligiuri, Stefano Gitto, Giulia Lori, Fabio Marra, Maurizio Parola, Stefania Cannito, Alessandra Gentilini

“…Primary liver cancers represent the third-most-common cause of cancer-related mortality worldwide, with an incidence of 80–90% for hepatocellular carcinoma (HCC) and 10–15% for cholangiocarcinoma (CCA), and an increasing morbidity and mortality rate. …”
Get full text

PGM5: a novel diagnostic and prognostic biomarker for liver cancer by Yan Jiao, Yanqing Li, Peiqiang Jiang, Wei Han, Yahui Liu

Subjects: “…Liver cancer…”
Get full text

Sleep Disturbance Affects Immune Factors in Clinical Liver Cancer Patients by Zuoyun Wang, Yan Wang, Jing Huang, Jietian Xu, Fangzhen Chen, Zidan Zhu, Lingling Gao, Jie Qin, Binbin Liu, Chunmin Liang

Subjects: “…liver cancer…”
Get full text

Development of Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer: An Update by Bryan D. Fleming, Mitchell Ho

“…Hepatocellular carcinoma (HCC) accounts for most liver cancers and represents one of the deadliest cancers in the world. …”
Get full text

Utilization pattern of traditional Chinese medicine for liver cancer patients in Taiwan by Liao Yueh-Hsiang, Lin Cheng-Chieh, Li Tsai-Chung, Lin Jaung-Geng

“…</p> <p>Results</p> <p>A total of 6358 liver cancer patients utilized ambulatory care during the study period. …”
Get full text

Benign focal liver lesions masquerading as primary liver cancers on MRI by Manickam Subramanian, Hsien Min Low, Myeong-Jin Kim, Cher Heng Tan

Get full text

Quantitative analysis of artificial intelligence on liver cancer: A bibliometric analysis by Ming Xiong, Yaona Xu, Yang Zhao, Si He, Qihan Zhu, Yi Wu, Xiaofei Hu, Li Liu, Li Liu

Subjects: Get full text

Impact of a deep learning assistant on the histopathologic classification of liver cancer by Amirhossein Kiani, Bora Uyumazturk, Pranav Rajpurkar, Alex Wang, Rebecca Gao, Erik Jones, Yifan Yu, Curtis P. Langlotz, Robyn L. Ball, Thomas J. Montine, Brock A. Martin, Gerald J. Berry, Michael G. Ozawa, Florette K. Hazard, Ryanne A. Brown, Simon B. Chen, Mona Wood, Libby S. Allard, Lourdes Ylagan, Andrew Y. Ng, Jeanne Shen

“…In this study, we developed a deep learning-based assistant to help pathologists differentiate between two subtypes of primary liver cancer, hepatocellular carcinoma and cholangiocarcinoma, on hematoxylin and eosin-stained whole-slide images (WSI), and evaluated its effect on the diagnostic performance of 11 pathologists with varying levels of expertise. …”
Get full text

An Updated Review on Advances in Hydrogel-Based Nanoparticles for Liver Cancer Treatment by Bahareh Farasati Far, Ali Attaripour Isfahani, Elnaz Nasiriyan, Ali Pourmolaei, Golnaz Mahmoudvand, Arian Karimi Rouzbahani, Mohammed Namiq Amin, Mohammad Reza Naimi-Jamal

Subjects: Get full text

Eicosanoids and other oxylipins in liver injury, inflammation and liver cancer development by Mario M. Alba, Brandon Ebright, Brittney Hua, Ielyzaveta Slarve, Yiren Zhou, Yunyi Jia, Stan G. Louie, Bangyan L. Stiles, Bangyan L. Stiles

“…Liver cancer is a malignancy developed from underlying liver disease that encompasses liver injury and metabolic disorders. …”
Get full text